Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection

NCT02707900 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided.

Conditions

Interventions

Sponsor

University of North Carolina, Chapel Hill

Collaborators